Alexandros D Tselepis (Styliani Papadaki, A D Tselepis, Alexandros Tselepis)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Rheumatoid Arthritis

Endothelial Cells

Cardiovascular Disease

Top Venues

Journal of cardiovascular development and disease

Pharmaceuticals (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Petros Spyridonas Adamidis, Despoina Pantazi, Iraklis C Moschonas, Evangelos N Liberopoulos, Alexandros D Tselepis
Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect? Journal of cardiovascular development and disease 11 (3) (2024)
Louisa Pechlivani, Nikoleta Ntemou, Despoina Pantazi, Dimitrios Alivertis, Konstantinos Skobridis, Alexandros D Tselepis
Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Petros Spyridonas Adamidis, Despoina Pantazi, Iraklis C Moschonas, Evangelos N Liberopoulos, Alexandros D Tselepis
Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect? Journal of cardiovascular development and disease 11 (3) (2024)
Louisa Pechlivani, Nikoleta Ntemou, Despoina Pantazi, Dimitrios Alivertis, Konstantinos Skobridis, Alexandros D Tselepis
Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Petros Spyridonas Adamidis, Despoina Pantazi, Iraklis C Moschonas, Evangelos N Liberopoulos, Alexandros D Tselepis
Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect? Journal of cardiovascular development and disease 11 (3) (2024)
Louisa Pechlivani, Nikoleta Ntemou, Despoina Pantazi, Dimitrios Alivertis, Konstantinos Skobridis, Alexandros D Tselepis
Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Antonios D Tsiailanis, Constantinos C Tellis, Paraskevi Papakyriakopoulou, Androniki D Kostagianni, Vasileios Gkalpinos, Christos M Chatzigiannis, Nikolaos G Kostomitsopoulos, Georgia Valsami, Alexandros D Tselepis, Andreas G Tzakos
Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen. Molecules (Basel, Switzerland) 28 (5) (2023)
Antonios D Tsiailanis, Constantinos C Tellis, Paraskevi Papakyriakopoulou, Androniki D Kostagianni, Vasileios Gkalpinos, Christos M Chatzigiannis, Nikolaos G Kostomitsopoulos, Georgia Valsami, Alexandros D Tselepis, Andreas G Tzakos
Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen. Molecules (Basel, Switzerland) 28 (5) (2023)
Antonios D Tsiailanis, Constantinos C Tellis, Paraskevi Papakyriakopoulou, Androniki D Kostagianni, Vasileios Gkalpinos, Christos M Chatzigiannis, Nikolaos G Kostomitsopoulos, Georgia Valsami, Alexandros D Tselepis, Andreas G Tzakos
Development of a Novel Apigenin Dosage form as a Substitute for the Modern Triple Antithrombotic Regimen. Molecules (Basel, Switzerland) 28 (5) (2023)
G V Papamichail, Athanasios Georgiadis, Constantinos Tellis, I Rapti, Theodora E Markatseli, V G Xydis, Alexandros D Tselepis, Alexandros A Drosos, Paraskevi Vasileios Voulgari
Antibodies against oxidized LDL and atherosclerosis in rheumatoid arthritis patients treated with biological agents: a prospective controlled study. Clinical rheumatology (2023)
Despoina Pantazi, Constantinos Tellis, Alexandros D Tselepis
"SI: PAF" Oxidized phospholipids and lipoprotein-associated phospholipase A 2 (Lp-PLA 2 ) in atherosclerotic cardiovascular disease: An update. BioFactors (Oxford, England) (2022)
Sofia Sidiropoulou, Styliani Papadaki, Aikaterini N Tsouka, Ioannis K Koutsaliaris, Vasileios G Chantzichristos, Despoina Pantazi, Minas E Paschopoulos, Kenny M Hansson, Alexandros D Tselepis
The Effect of Platelet-Rich Plasma on Endothelial Progenitor Cell Functionality. Angiology 72 (8) (2021)
Amalia Despoina Koutsogianni, Evangelos Liberopoulos, Konstantinos Tellis, Alexandros D Tselepis
Oxidized phospholipids and lipoprotein(a): An update. European journal of clinical investigation (2021)
Evangelia Dounousi, Constantinos Tellis, Paraskevi Pavlakou, Anila Duni, Vasillios Liakopoulos, Patrick B Mark, Aikaterini Papagianni, Alexandros D Tselepis
Association between PCSK9 Levels and Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction in a Population of Nondialysis Chronic Kidney Disease Patients. Oxidative medicine and cellular longevity 2021 (2021)
Aikaterini Gatsiou, Kateryna Sopova, Alexandros D Tselepis, Konstantinos Stellos
Interleukin-17A Triggers the Release of Platelet-Derived Factors Driving Vascular Endothelial Cells toward a Pro-Angiogenic State. Cells 10 (8) (2021)
Alexandros D Tselepis, Alexandros D Tselepis
Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants? Angiology 70 (10) (2019)